Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,661 across all filing types
Latest filing 2021-04-09 Regulatory Filings
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we hereby confirm that all activities related to physical and electronic ....
Regulatory Filings Classification · 95% confidence The document is a compliance certificate addressed to stock exchanges (NSE and BSE) pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the half year ended 31 March 2021. It confirms that share transfer activities are maintained by the company's Registrar and Share Transfer Agent. The document is short (1719 characters) and is a certification letter rather than a financial report or detailed filing. It does not contain financial statements or substantive financial data. Therefore, it fits the criteria for a Regulatory Filing (RNS) as it is a compliance certificate and not a full report or announcement of a report.
2021-04-09 English
Defaults on Payment of Interest/Principal
Regulatory Filings Classification · 95% confidence The document is a quarterly disclosure related to the status of defaults on payment of interest/repayment of principal amount on loans and unlisted debt securities, as per SEBI Circular dated November 21, 2019. It provides specific financial data as of March 31, 2021, including amounts outstanding and defaults. The document is a regulatory compliance disclosure rather than a full financial report or earnings release. It is not a full interim or quarterly report with comprehensive financial statements, but a specific regulatory update. Given the nature and length (2618 characters), it is not a report publication announcement but a regulatory filing. Therefore, the appropriate classification is Regulatory Filings (RNS).
2021-04-07 English
Updates
Capital/Financing Update Classification · 95% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) regarding the issuance and allotment of fully convertible warrants to promoter group persons. It mentions the number of warrants issued and requests the exchanges to take note of the allotment. There is no financial data, no detailed report, no earnings information, no management discussion, or any other detailed disclosure. The document is an announcement of a capital market transaction (issuance of warrants) and is relatively short (1697 characters). This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes such as issuance of convertible warrants.
2021-04-06 English
In continuation to the earlier intimations/ disclosures regarding the captioned subject and requisite 'in-principle' approvals received from NSE & BSE. It may please be noted ....
Capital/Financing Update Classification · 95% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) regarding the issuance and allotment of fully convertible warrants to promoter group persons. It mentions the number of warrants issued and requests the exchanges to take the information on record. There is no financial data, no detailed report, no earnings information, no management discussion, or any other report type content. The document is an announcement of a capital raising activity (issuance of warrants) and is a regulatory disclosure to stock exchanges. This fits the category of Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or certification. Therefore, the best classification is CAP with high confidence.
2021-04-06 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the loss of share certificates and the request for issuance of duplicate share certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and related disclosures. The document does not contain financial data, earnings, management discussion, or any report content. It is an official notification about a specific shareholder-related event (loss of share certificates). This fits best under Regulatory Filings (RNS) as it is a regulatory disclosure that does not fit other specific categories like share issue or director dealings.
2021-04-01 English
Intimation of loss of certificates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (NSE and BSE) regarding the loss of share certificates by shareholders and the request for issuance of duplicate share certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and related disclosures. The content is a notification or intimation about specific shareholder share certificate losses, not a financial report, earnings release, or management discussion. It does not contain financial data, management changes, voting results, or legal proceedings. The document is essentially an official regulatory announcement to the stock exchanges about share certificate loss cases. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-04-01 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.